TipRanks
Sanofi (DE:SNW2)
FRANKFURT:SNW2
Germany Market

Sanofi (SNW2) Drug Pipeline

1 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Bivalent Rsv+Hmpv Protein Vaccine
Healthy Volunteers, Respiratory Syncytial Virus, Human Metapneumovirus
Phase II
Recruiting
Phase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and Older
Sep 03, 2026
Lunsekimig, Sar443765
Chronic Obstructive Pulmonary Disease
Phase III
Recruiting
A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Aug 25, 2026
Acne Mrna Vaccine
Acne
Phase II
Not Yet Recruiting
Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne
Aug 04, 2026
Flu H5 Egg Pandemic Low Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic Medium Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, Without Adjuvant
Healthy Volunteers, Influenza
Phase I/II
Not Yet Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Jul 31, 2026
Belumosudil
Chronic Graft Versus Host Disease
Phase I
Not Yet Recruiting
Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants
Jul 21, 2026
Rsv+Hmpv Vaccine, Control Vaccine 3, Control Vaccine 4, Control Vaccine 2, Control Vaccine 1
Healthy Volunteers, Respiratory Syncytial Virus Immunization, Human Metapneumovirus Immunization
Phase I/II
Recruiting
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Jul 21, 2026
Menquadfi, Menhycia
Healthy Volunteers, Meningococcal Infection
Phase III
Recruiting
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China
Jul 13, 2026
―
Dupilumab, Dupilumab Coformulated With Berahyaluronidase Alfa, Sar231893, Dupixent
Healthy Volunteers
Phase I
Active Not Recruiting
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
Jun 08, 2026
―
Blu-924
Colorectal Neoplasms, Non-small Cell Lung Cancer, Advanced Solid Tumor, Pancreatic Ductal Adenocarcinoma
Phase I/II
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Jun 01, 2026
Sar447971
Healthy Volunteers, Hidradenitis
Phase I
Recruiting
SAR447971 First-in-human Study
May 22, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Sanofi (SNW2) have in its pipeline
      SNW2 is currently developing the following drugs: Bivalent Rsv+Hmpv Protein Vaccine, Lunsekimig, Sar443765, Acne Mrna Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.